ReviewPeerJ2026
Oropouche virus infection: an emerging arboviral threat in Asia.
Review in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oropouche virus (OROV), a neglected arbovirus of the Methodology: This narrative literature review was conducted using PubMed, Scopus, and Web of Science from September 2025 to May 2026. A total of 7,939 records were initially identified, and 105 relevant sources were selected based on their relevance to OROV virology, transmission dynamics, clinical manifestations, evolutionary potential, environmental drivers, and possible emergence in Asia. Results: Current evidence shows that OROV has progressed from a regionally neglected arbovirus to an emerging preparedness concern. Its segmented RNA genome enables reassortment, supporting viral adaptability and the emergence of strains such as OROVBR-2015-2024, which have been associated with enhanced transmission potential and more severe clinical outcomes. In Asia, potential emergence would likely result from multiple converging factors rather than a single determinant. These include the presence of diverse biting midges and mosquitoes that require vector competence assessment, climate conditions favourable to vector persistence, land-use change, urbanisation, increased wildlife-livestock-human contact, and frequent international travel. Clinical overlap with dengue, Zika, and chikungunya may further delay recognition, particularly in settings where OROV molecular testing is not routinely available. Conclusion: OROV emergence in Asia is not inevitable but remains a credible preparedness concern. Proactive surveillance, diagnostic readiness, vector competence studies, and regional preparedness are needed to enable early detection and reduce the risk of introduction and establishment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.